Page last updated: 2024-09-05

erlotinib hydrochloride and Hemorrhagic Fever, Ebola

erlotinib hydrochloride has been researched along with Hemorrhagic Fever, Ebola in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bekerman, E; Einav, S	1
Bakken, RR; Barouch-Bentov, R; Bekerman, E; Brannan, J; De Jonghe, S; Diamond, MS; Dye, JM; Einav, S; Govero, J; Herdewijn, P; Mateo, R; Nagamine, CM; Neveu, G; Pu, SY; Randall, G; Shulla, A; Wang, S; Xiao, F	1

Other Studies

2 other study(ies) available for erlotinib hydrochloride and Hemorrhagic Fever, Ebola

Article	Year
Infectious disease. Combating emerging viral threats. Science (New York, N.Y.), 2015, Apr-17, Volume: 348, Issue:6232 Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses	2015
Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects. The Journal of clinical investigation, 2017, Apr-03, Volume: 127, Issue:4 Topics: Adaptor Protein Complex 1; Adaptor Protein Complex 2; Animals; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Dengue; Dengue Virus; Drug Evaluation, Preclinical; Drug Synergism; Ebolavirus; Erlotinib Hydrochloride; Female; Hemorrhagic Fever, Ebola; Hepacivirus; Hepatitis C; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Male; Mice, 129 Strain; Mice, Inbred C57BL; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Pyrroles; Sunitinib; Virus Internalization	2017

Article

Year

Infectious disease. Combating emerging viral threats.

Science (New York, N.Y.), 2015, Apr-17, Volume: 348, Issue:6232

Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses

2015

Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects.

The Journal of clinical investigation, 2017, Apr-03, Volume: 127, Issue:4

Topics: Adaptor Protein Complex 1; Adaptor Protein Complex 2; Animals; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Dengue; Dengue Virus; Drug Evaluation, Preclinical; Drug Synergism; Ebolavirus; Erlotinib Hydrochloride; Female; Hemorrhagic Fever, Ebola; Hepacivirus; Hepatitis C; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Male; Mice, 129 Strain; Mice, Inbred C57BL; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Pyrroles; Sunitinib; Virus Internalization

2017